These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23225191)

  • 21. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.
    Piana PM; Gonsalves CF; Sato T; Anne PR; McCann JW; Bar Ad V; Eschelman DJ; Parker L; Doyle LA; Brown DB
    J Vasc Interv Radiol; 2011 Oct; 22(10):1373-9. PubMed ID: 21764600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioembolization for hepatocellular carcinoma.
    Sangro B; Iñarrairaegui M; Bilbao JI
    J Hepatol; 2012 Feb; 56(2):464-73. PubMed ID: 21816126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S; Lau WY; Leung WT
    Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
    [No Abstract]   [Full Text] [Related]  

  • 25. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
    Feng M; Suresh K; Schipper MJ; Bazzi L; Ben-Josef E; Matuszak MM; Parikh ND; Welling TH; Normolle D; Ten Haken RK; Lawrence TS
    JAMA Oncol; 2018 Jan; 4(1):40-47. PubMed ID: 28796864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
    Hilgard P; Hamami M; Fouly AE; Scherag A; Müller S; Ertle J; Heusner T; Cicinnati VR; Paul A; Bockisch A; Gerken G; Antoch G
    Hepatology; 2010 Nov; 52(5):1741-9. PubMed ID: 21038413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?
    Edeline J; Lenoir L; Boudjema K; Rolland Y; Boulic A; Le Du F; Pracht M; Raoul JL; Clément B; Garin E; Boucher E
    Ann Surg Oncol; 2013 Aug; 20(8):2518-25. PubMed ID: 23494107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
    Atassi B; Bangash AK; Lewandowski RJ; Ibrahim S; Kulik L; Mulcahy MF; Murthy R; Ryu RK; Sato KT; Miller FH; Omary RA; Salem R
    J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
    Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
    J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
    Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
    Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice.
    Radosa CG; Radosa JC; Grosche-Schlee S; Zöphel K; Plodeck V; Kühn JP; Kotzerke J; Hoffmann RT
    Cardiovasc Intervent Radiol; 2019 Mar; 42(3):405-412. PubMed ID: 30603976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
    Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R
    Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
    Soydal C; Kucuk ON; Bilgic S; Ibis E
    Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation.
    Fernandez-Ros N; Iñarrairaegui M; Paramo JA; Berasain C; Avila MA; Chopitea A; Varo N; Sarobe P; Bilbao JI; Dominguez I; D'Avola D; Herrero JI; Quiroga J; Sangro B
    Liver Int; 2015 May; 35(5):1590-6. PubMed ID: 24836705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound in radioembolization induced liver disease (REILD).
    Bohle W; Zoller WG
    Z Gastroenterol; 2015 Aug; 53(8):798-801. PubMed ID: 26284329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
    Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H
    J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.